This post has been archived and contains information that may be out of date.
What’s happening: On Nov. 28, the Office of Health Care Affordability (OHCA) released a revised version of the cost and market impact review regulations, alongside an accompanying notice. What else to know: The final regulations are expected to be effective on Jan. 1, 2024, for transactions intended to be completed on or after April 1,...
This post has been archived and contains information that may be out of date.
Over the past year, the state’s newly formed Office of Health Care Affordability has been convening and debating ways to meet the office’s legislated mission to reduce health care spending growth and ensure the delivery of high-quality, equitable care.
This post has been archived and contains information that may be out of date.
What’s happening: Draft regulations outline how spending will be tracked for monitoring performance against the spending target.
What else to know: Stakeholders can provide written comments (due Dec. 1) and public comment at a Nov. 14 workshop.
This post has been archived and contains information that may be out of date.
This week, CHA shared two letters with the Office of Health Care Affordability (OHCA).
This post has been archived and contains information that may be out of date.
Earlier this week, the Office of Health Care Affordability released a revised draft regulation on the cost and market impact review process. The revised draft regulations include several notable improvements compared to the prior version, most notably exempting from review transactions in the usual and regular course of business and establishing an expedited review process...
This post has been archived and contains information that may be out of date.
Earlier this week, CHA commented on the June 2023 meetings of the Health Care Affordability Board and Advisory Committee. The letter focuses on the office’s market oversight functions, as well as key issues related to the office’s spending targets and data collection efforts.
This post has been archived and contains information that may be out of date.
Last month, CHA wrote to the Health Care Affordability Board to publicly comment on several important issues currently under discussion and consideration by the board.